ESR1 and breast cancer: Similarly, previous studies showed that post-menopausal breast cancer patients have high testosterone levels and high expression of AR, which were significantly associated with the ER+ status of the tumors (OR 2.42; 95% CI, 1.22-4.82) [10, 11].